1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Crystalglobulin-Associated Kidney Disease: A Case Report and Literature Review

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The kidney is commonly involved in multiple myeloma and other disorders producing monoclonal immunoglobulins. Crystalglobulinemia is a rare condition characterized by spontaneous crystallization and deposition of monoclonal immunoglobulins within the microvasculature of the kidney and other organs, leading to inflammation, ischemia, and end-organ damage. The present case and literature review highlight the clinical spectrum, diagnostic challenges, management, and outcomes of this underrecognized complication of monoclonal gammopathy. Crystalglobulin-associated kidney disease should be suspected in patients with rapidly progressive kidney disease associated with hematuria, proteinuria, extrarenal lesions (ie, skin and joints), and monoclonal gammopathy. Kidney biopsy is critical to the diagnosis, which relies on the identification by ultrastructural analysis of electron-dense crystalline structures composed of a monoclonal immunoglobulin within the kidney microvasculature. Conventional immunofluorescence on frozen tissue frequently fails to detect monoclonal protein deposits, and pronase-based antigen retrieval on paraffin-embedded material or immunoelectron microscopy is required to unmask antigenic epitopes located within crystalline inclusions. Early intervention combining treatment of clonal cell proliferation and plasma exchanges is warranted to reduce the burden of this rare but dramatic complication of monoclonal gammopathy.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          How I treat monoclonal gammopathy of renal significance (MGRS).

          Recently, the term monoclonal gammopathy of renal significance (MGRS) was introduced to distinguish monoclonal gammopathies that result in the development of kidney disease from those that are benign. By definition, patients with MGRS have B-cell clones that do not meet the definition of multiple myeloma or lymphoma. Nevertheless, these clones produce monoclonal proteins that are capable of injuring the kidney resulting in permanent damage. Except for immunoglobulin light chain amyloidosis with heart involvement in which death can be rapid, treatment of MGRS is often indicated more to preserve kidney function and prevent recurrence after kidney transplantation rather than the prolongation of life. Clinical trials are rare for MGRS-related kidney diseases, except in immunoglobulin light chain amyloidosis. Treatment recommendations are therefore based on the clinical data obtained from treatment of the clonal disorder in its malignant state. The establishment of these treatment recommendations is important until data can be obtained by clinical trials of MGRS-related kidney diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies.

            Direct immunofluorescence (IF) on frozen tissue is the method of choice for the study of medical renal diseases. When no glomeruli are available, IF can be performed on the formalin-fixed paraffin-embedded tissue allocated for light microscopy after antigen retrieval with proteases. In this study, the results of IF on frozen tissue (IF-F) and on deparaffinized, pronase-treated tissue (IF-P) were compared in 71 renal biopsies representing 12 major renal diseases. Using IF-P, diagnostic findings were obtained in 100% of cases of lupus nephritis, acute post-infectious glomerulonephritis, cryoglobulinemic glomerulonephritis, fibrillary glomerulonephritis, primary amyloidosis, myeloma cast nephropathy, and light-chain Fanconi syndrome (LCFS), 88% of cases of immunoglobulin (Ig)A nephropathy, 80% of cases of light-chain deposition disease, 60% of cases of membranoproliferative glomerulonephritis type 1, 50% of cases of idiopathic membranous glomerulopathy (MGN) and 20% of cases of anti-glomerular basement membrane (GBM) disease. IF-P was less sensitive than IF-F for the detection of C3 in all disease categories and for the detection of IgG in cases of MGN and anti-GBM disease. The diagnostic kappa light-chain staining was demonstrated in 100% of cases of LCFS by IF-P versus 40% by IF-F. We conclude that IF-P is a valuable salvage immunohistochemical technique for renal biopsies lacking adequate cortical sampling for IF-F, and is superior to IF-F for the diagnosis of LCFS.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Monoclonal Gammopathy of Renal Significance

                Bookmark

                Author and article information

                Contributors
                Journal
                Kidney Med
                Kidney Med
                Kidney Medicine
                Elsevier
                2590-0595
                10 March 2022
                May 2022
                10 March 2022
                : 4
                : 5
                : 100445
                Affiliations
                [1 ]Division of Nephrology, Cliniques universitaires Saint-Luc, Brussels, Belgium
                [2 ]Department of Pathology, Cliniques universitaires Saint-Luc, Brussels, Belgium
                [3 ]Division of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium
                [4 ]Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium
                [5 ]Division of Nephrology, Centre Hospitalier Régional Mons-Hainaut, Groupe Jolimont, Mons, Belgium
                [6 ]Division of Nephrology, Centre Hospitalier Universitaire de Poitiers, INSERM CIC 1402, Poitiers, France
                [7 ]Centre de Référence Maladies Rares, Amylose AL et Autres Maladies par Dépôt d'Immunoglobulines Monoclonales, Centre Hospitalier Universitaire de Poitiers, INSERM CIC 1402, Poitiers, France
                Author notes
                [] Address for Correspondence: Johann Morelle, MD, PhD, Division of Nephrology, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, B-1200 Brussels, Belgium. johann.morelle@ 123456uclouvain.be
                Article
                S2590-0595(22)00057-7 100445
                10.1016/j.xkme.2022.100445
                9035433
                25bd2190-b208-410e-bf44-1c137d842a77
                © 2022 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Case Report

                crystalglobulinemia,kidney biopsy,kidney failure,monoclonal gammopathy,monoclonal gammopathy of renal significance,multiple myeloma

                Comments

                Comment on this article